Jacobs Levy Equity Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-69,762
| Closed | -$548K | – | 1029 |
|
|
2023
Q1 | $548K | Buy |
+69,762
| New | +$548K | ﹤0.01% | 792 |
|
|
2021
Q2 | – | Sell |
-47,681
| Closed | -$1.23M | – | 1076 |
|
|
2021
Q1 | $1.23M | Sell |
47,681
-5,796
| -11% | -$149K | 0.01% | 691 |
|
|
2020
Q4 | $1.02M | Buy |
53,477
+18,915
| +55% | +$359K | 0.01% | 717 |
|
|
2020
Q3 | $435K | Buy |
34,562
+18,434
| +114% | +$232K | ﹤0.01% | 824 |
|
|
2020
Q2 | $195K | Buy |
+16,128
| New | +$195K | ﹤0.01% | 957 |
|